The Macurra SARS-CoV-2 PCR Kit is a qualitative assay that allows the detection of nucleic acids in samples from patients who meet COVID-19 (coronavirus) clinical and/or epidemiological criteria. It is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories. Request Information
• Single-well triple target assay to prevent missing detection:
Simultaneous detection of the three genes of ORF1ab / E / N in SARS-CoV-2. The assay has a full-process negative control, positive control and internal control.
• Added internal control to monitor the whole process:
For each test, an internal control is added to the test reagent to prevent false negative test results.
• Simulated virus to ensure quality:
The positive control and internal control of the kit are simulated RNA virus particles, which are similar to the virus structure, and coated with protein as well. The controls join the extraction step with the samples at the same time, which makes it easier to monitor the entire experimental process and ensure the reliability of the test results. Request Information